Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 14Prostate Adenocarcinoma 2Wilms Tumor 1Urothelial Carcinoma of the Bladder 1Stage I Prostate Adenocarcinoma AJCC v7 1Radiation Injuries 1Neoplasms 1Glioma 1Carcinoma, Hepatocellular 1

Interventions

Magnetic Resonance Spectroscopy 5Radiosurgery 4luprolide acetate gel depot 3enzalutamide 3Radiotherapy 3Radiation 3Leuprolide 3Goserelin 3relugolix 2gallium 68 PSMA-11 2bicalutamide 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Triptorelin Pamoate 2Specimen Handling 2Proton Therapy 2Biopsy 2radium Ra 223 dichloride 1niraparib 1histrelin 1fluciclovine F-18 1flibanserin 1entinostat 1darolutamide 1atezolizumab 1apalutamide 1abiraterone 1X-Rays 1Watchful Waiting 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostate Adenocarcinoma × Proton Therapy × Genitourinary × Clear all
NCT01352429 2025-07-17

Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Abramson Cancer Center at Penn Medicine

Active not recruiting
303 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT03285815 2017-09-18

Prostate Cancer - Localized Adenocarcinoma Proton Therapy

National Cancer Center, Korea

Phase NA Unknown
156 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡